​

Quest Diagnostics (DGX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

DGX Stock Forecast

Quest Diagnostics (DGX) stock forecast, based on 34 Wall Street analysts, predicts a 12-month average price target of $201.60, with a high of $215.00 and a low of $190.00. This represents a 11.84% increase from the last price of $180.26.

$120 $139 $158 $177 $196 $215 High: $215 Avg: $201.6 Low: $190 Last Closed Price: $180.26

DGX Stock Rating

Quest Diagnostics stock's rating consensus is Hold, based on 34 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 12 Buy (35.29%), 19 Hold (55.88%), 3 Sell (8.82%), and 0 Strong Sell (0.00%).

Hold
Total 34 3 19 12 0 Strong Sell Sell Hold Buy Strong Buy

DGX Price Target Upside V Benchmarks

TypeNameUpside
StockQuest Diagnostics11.84%
SectorHealthcare Stocks 15.45%
IndustryDiagnostics & Research Stocks6.76%

Price Target Trends

1M3M12M
# Anlaysts111217
Avg Price Target$200.64$200.08$196.00
Last Closing Price$180.26$180.26$180.26
Upside/Downside11.31%11.00%8.73%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 25179-118
Sep, 251710--18
Aug, 25189--18
Jul, 25189-119
Jun, 251810--19
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 27, 2025Piper Sandler$200.00$182.189.78%10.95%
Oct 22, 2025Truist Financial$205.00$184.6411.03%13.72%
Oct 22, 2025Erin WrightMorgan Stanley$207.00$183.1813.00%14.83%
Oct 22, 2025Barclays$195.00$183.186.45%8.18%
Oct 21, 2025Jefferies$215.00$183.3417.27%19.27%
Oct 21, 2025Leerink Partners$210.00$184.1014.07%16.50%
Oct 17, 2025Kevin CaliendoUBS$190.00$186.821.70%5.40%
Oct 17, 2025Mizuho Securities$210.00$186.8212.41%16.50%
Oct 14, 2025Truist Financial$195.00$184.005.98%8.18%
Oct 08, 2025Evercore ISI$190.00$181.894.46%5.40%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 27, 2025Piper SandlerNeutralNeutralhold
Oct 22, 2025Morgan StanleyOverweightOverweighthold
Oct 21, 2025JefferiesBuyBuyhold
Oct 21, 2025Leerink PartnersOutperformOutperformhold
Oct 17, 2025UBSNeutralNeutralhold
Mar 04, 2025CitigroupBuyNeutraldowngrade
Oct 23, 2024CitigroupBuyBuyhold
Oct 23, 2024Leerink PartnersMarket PerformMarket Performhold
Oct 23, 2024BarclaysEqual-WeightEqual-Weighthold
Aug 27, 2024BarclaysEqual-WeightEqual-Weighthold

Financial Forecast

EPS Forecast

$7 $8 $9 $10 $11 $12 $13 $14 $15 $16 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$10.68$15.90$8.12$7.59$7.80----
Avg Forecast$10.80$14.12$9.85$8.71$8.90$9.73$10.51$11.56$12.71
High Forecast$11.33$14.81$10.03$8.75$8.93$9.77$12.37$12.45$13.00
Low Forecast$10.32$13.49$9.53$8.68$8.87$9.70$9.86$10.67$12.13
Surprise %-1.11%12.61%-17.56%-12.86%-12.36%----

Revenue Forecast

$9B $10B $10B $11B $12B $13B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$9.44B$10.79B$9.88B$9.25B$9.87B----
Avg Forecast$9.34B$10.74B$9.83B$9.22B$9.83B$10.71B$11.13B$11.68B$12.06B
High Forecast$9.70B$11.15B$9.97B$9.24B$9.84B$10.84B$11.17B$11.88B$12.27B
Low Forecast$9.02B$10.37B$9.58B$9.20B$9.81B$10.50B$11.10B$11.49B$11.63B
Surprise %1.01%0.44%0.54%0.39%0.43%----

Net Income Forecast

$500M $900M $1B $2B $2B $3B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.43B$2.00B$946.00M$854.00M$871.00M----
Avg Forecast$1.30B$1.71B$1.31B$850.00M$1.01B$1.10B$1.26B$1.38B$1.44B
High Forecast$1.56B$2.06B$1.57B$1.02B$1.01B$1.10B$1.40B$1.41B$1.47B
Low Forecast$1.04B$1.37B$1.04B$680.00M$1.00B$1.10B$1.11B$1.21B$1.37B
Surprise %9.82%16.48%-27.57%0.47%-13.39%----

DGX Forecast FAQ

Is Quest Diagnostics stock a buy?

Quest Diagnostics stock has a consensus rating of Hold, based on 34 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 12 Buy, 19 Hold, 3 Sell, and 0 Strong Sell, reflecting a consensus that Quest Diagnostics is a neutral investment for most analysts.

What is Quest Diagnostics's price target?

Quest Diagnostics's price target, set by 34 Wall Street analysts, averages $201.6 over the next 12 months. The price target range spans from $190 at the low end to $215 at the high end, suggesting a potential 11.84% change from the previous closing price of $180.26.

How does Quest Diagnostics stock forecast compare to its benchmarks?

Quest Diagnostics's stock forecast shows a 11.84% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the diagnostics & research stocks industry (6.76%).

What is the breakdown of analyst ratings for Quest Diagnostics over the past three months?

  • October 2025: 5.56% Strong Buy, 38.89% Buy, 50.00% Hold, 0% Sell, 5.56% Strong Sell.
  • September 2025: 5.56% Strong Buy, 38.89% Buy, 55.56% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 5.56% Strong Buy, 44.44% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.

What is Quest Diagnostics’s EPS forecast?

Quest Diagnostics's average annual EPS forecast for its fiscal year ending in December 2025 is $9.73, marking a 24.74% increase from the reported $7.8 in 2024. Estimates for the following years are $10.51 in 2026, $11.56 in 2027, and $12.71 in 2028.

What is Quest Diagnostics’s revenue forecast?

Quest Diagnostics's average annual revenue forecast for its fiscal year ending in December 2025 is $10.71B, reflecting a 8.47% increase from the reported $9.87B in 2024. The forecast for 2026 is $11.13B, followed by $11.68B for 2027, and $12.06B for 2028.

What is Quest Diagnostics’s net income forecast?

Quest Diagnostics's net income forecast for the fiscal year ending in December 2025 stands at $1.1B, representing an 26.27% increase from the reported $871M in 2024. Projections indicate $1.26B in 2026, $1.38B in 2027, and $1.44B in 2028.